Pegylated Interferon alpha 2-b

Medical Advocates
Pegylated Interferon Alfa-2b (PEG-INTRON)

HIV/HCV Journal Citations: Efficacy

General Reports
Chronic HIV

Peg Inf Alfa-2b HIV/HCV Journal Citations

Main New/Newsworthy

Home Page

Last Update: January 26, 2015

General Reports

Journal Papers, Abstracts, and Commentaries

FULL-TEXT ARTICLE
HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
Rivero-Juarez A, López-Cortés LF, Camacho A, et al
PLoS One. 2014 Jun 19;9(6):e99468.
Paper

A WEEK-IN-REVIEW FEATURED REPORT
Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of
HIV/HCV co-infected patients.
Neumann A, Polis M, Rozenberg L, et al
AIDS. 2007 Sep;21(14):1855-1865.
Abstract

Conference Reports, Abstracts, and Posters

Efficacy of acute HCV treatment with peg-interferon a-2b and ribavirin in HIV infected patients
A Kruk
(3rd IAS)
Abstract

Moderate dose of PegInterferon alfa-2b in combination with ribavirin in the
treatment of HCV patients with or without HIV
C Sarmento, A Horta, H Coelho, O Vasconcelos, et al
(3rd IAS)
Abstract

Chronic HCV

Journal Papers, Abstracts, and Commentaries

Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C
in HIV-coinfected patients.
Crespo M, Sauleda S, Esteban JI, et al
J Viral Hepat. 2007 Apr;14(4):228-38.
Abstract

Rapid and early virological response to chronic Hepatitis C treatment with IFN {alpha}2b or
PEG-IFN & [alpha]2b plus ribavirin in HIV/HCV co-infected patients.
Payan C, Pivert A, Morand P, et al
Gut. 2007 Mar 15
Abstract

Peg Inf Alfa-2b HIV/HCV Journal Citations Main New/Newsworthy Home Page

Peginterferon Afa-2b
HIV/HCV Journal Citations
Efficacy